Soluble Urokinase-Type Plasminogen Activator Receptor in Comatose Survivors After Out-of-Hospital Cardiac Arrest Treated with Targeted Temperature Management-Reference-Cited by-同舟云学术

Soluble Urokinase-Type Plasminogen Activator Receptor in Comatose Survivors After Out-of-Hospital Cardiac Arrest Treated with Targeted Temperature Management

Published:2023-11-01 Issue: Volume: Page:
ISSN:2153-7658
Container-title:Therapeutic Hypothermia and Temperature Management
language:en
Short-container-title:Therapeutic Hypothermia and Temperature Management

Author:

Bro-Jeppesen John¹^ORCID,Grejs Anders M.²³,Andersen Ove⁴,Jeppesen Anni N.⁵,Duez Christophe⁶,Kirkegaard Hans³⁷

Affiliation:

1. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

2. Department of Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.

3. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

4. Department of Clinical Research and Emergency, Amager and Hvidovre Hospital, Hvidovre, Denmark.

5. Department of Cardiothoracic and Vascular Surgery, Anaesthesia Section, Aarhus University Hospital, Aarhus, Denmark.

6. Department of Otolaryngology, Goedstrup Hospital, Central Denmark Region, Glostrup, Denmark.

7. Research Center for Emergency Medicine, Aarhus University Hospital, Aarhus, Denmark.

Publisher

Mary Ann Liebert Inc

Subject

Anesthesiology and Pain Medicine,Critical Care and Intensive Care Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/ther.2023.0039

Reference23 articles.

1. Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome

2. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome?

3. Effect of Hypothermia and Targeted Temperature Management on Drug Disposition and Response Following Cardiac Arrest: A Comprehensive Review of Preclinical and Clinical Investigations

4. Rewarming after hypothermia after cardiac arrest shifts the inflammatory balance*

5. Level of systemic inflammation and endothelial injury is associated with cardiovascular dysfunction and vasopressor support in post-cardiac arrest patients